Pharma stocks reeled under pressure on fears that the duty entitlement passbook (DEPB) benefits scheme may be withdrawn from the exporting companies, thus, hurt their overseas formulations.
first published: May 6, 2011 02:04 pm
A collection of the most-viewed Moneycontrol videos.
U.S.-Iran Conflict Will Have Huge Impact On Global Markets, Businesses, Supply Chain: Nalin Mehta
Rising Bharat Summit 2026 | “Satellite Can Go Where Others Can’t” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | “AI Creates More Opportunities” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | Piyush Goyal Answers the Big India–US Trade Deal Question
